Cytori Cell Research Institute Inc 3750
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 1,005.00
- Day Range
- JPY 978.00–1,002.00
- 52-Week Range
- JPY 881.00–1,284.00
- Bid/Ask
- JPY 977.00 / JPY 982.00
- Market Cap
- JPY 8.73 Bil
- Volume/Avg
- 3,200 / 14,902
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.71
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 119
- Website
- https://www.cytori.co.jp
Comparables
Valuation
|
Metric
|
3750
|
3245
|
3252
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 7.23 | 6.67 |
Price/Book Value | 4.27 | 1.77 | 1.15 |
Price/Sales | 4.71 | 0.96 | 0.78 |
Price/Cash Flow | — | 10.84 | 6.65 |
Price/Earnings
3750
3245
3252
Financial Strength
|
Metric
|
3750
|
3245
|
3252
|
|---|---|---|---|
Quick Ratio | 0.37 | 2.27 | 3.72 |
Current Ratio | 0.54 | 7.31 | 11.06 |
Interest Coverage | −5.36 | 34.10 | 19.78 |
Quick Ratio
3750
3245
3252
Profitability
|
Metric
|
3750
|
3245
|
3252
|
|---|---|---|---|
Return on Assets (Normalized) | −6.17% | 12.72% | 10.00% |
Return on Equity (Normalized) | −34.39% | 24.80% | 28.78% |
Return on Invested Capital (Normalized) | −6.67% | 13.76% | 11.14% |
Return on Assets
3750
3245
3252
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Kwmlkwkkh | Plhh | $635.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Jjzvzxb | Dgcfhzf | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Npjhlvnb | Fkgskbh | $114.2 Bil | |||
| Moderna Inc
MRNA
| Vghnzwkc | Gxzw | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Qzrxhhsc | Zlrht | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Xxwtgdvz | Bzgt | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Sfdlgjdxm | Vmfsg | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Ymhxvdxxm | Mhqzfhv | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Wzxtpcgj | Fby | $12.8 Bil | |||
| Incyte Corp
INCY
| Whdtlqv | Bgxbhw | $12.2 Bil |